These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22248822)

  • 1. FOXL2 impairment in human disease.
    Verdin H; De Baere E
    Horm Res Paediatr; 2012; 77(1):2-11. PubMed ID: 22248822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome.
    Corrêa FJ; Tavares AB; Pereira RW; Abrão MS
    Fertil Steril; 2010 Feb; 93(3):1006.e3-6. PubMed ID: 19969293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factor FOXL2 in ovarian function and dysfunction.
    De Baere E; Fellous M; Veitia RA
    Folia Histochem Cytobiol; 2009; 47(5):S43-9. PubMed ID: 20067892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxl2 function in ovarian development.
    Uhlenhaut NH; Treier M
    Mol Genet Metab; 2006 Jul; 88(3):225-34. PubMed ID: 16647286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXL2 mutations and genomic rearrangements in BPES.
    Beysen D; De Paepe A; De Baere E
    Hum Mutat; 2009 Feb; 30(2):158-69. PubMed ID: 18726931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human FOXL2 mutation database.
    Beysen D; Vandesompele J; Messiaen L; De Paepe A; De Baere E
    Hum Mutat; 2004 Sep; 24(3):189-93. PubMed ID: 15300845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation.
    De Baere E; Dixon MJ; Small KW; Jabs EW; Leroy BP; Devriendt K; Gillerot Y; Mortier G; Meire F; Van Maldergem L; Courtens W; Hjalgrim H; Huang S; Liebaers I; Van Regemorter N; Touraine P; Praphanphoj V; Verloes A; Udar N; Yellore V; Chalukya M; Yelchits S; De Paepe A; Kuttenn F; Fellous M; Veitia R; Messiaen L
    Hum Mol Genet; 2001 Jul; 10(15):1591-600. PubMed ID: 11468277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXL2 mutations lead to different ovarian phenotypes in BPES patients: Case Report.
    Méduri G; Bachelot A; Duflos C; Bständig B; Poirot C; Genestie C; Veitia R; De Baere E; Touraine P
    Hum Reprod; 2010 Jan; 25(1):235-43. PubMed ID: 19819892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins.
    Kim JH; Bae J
    J Reprod Dev; 2014 Mar; 60(1):14-20. PubMed ID: 24240106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction.
    Nallathambi J; Moumné L; De Baere E; Beysen D; Usha K; Sundaresan P; Veitia RA
    Hum Genet; 2007 Mar; 121(1):107-12. PubMed ID: 17089161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor FOXL2: at the crossroads of ovarian physiology and pathology.
    Caburet S; Georges A; L'Hôte D; Todeschini AL; Benayoun BA; Veitia RA
    Mol Cell Endocrinol; 2012 Jun; 356(1-2):55-64. PubMed ID: 21763750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature ovarian failure and forkhead transcription factor FOXL2: blepharophimosis-ptosis-epicanthus inversus syndrome and ovarian dysfunction.
    De Baere E; Copelli S; Caburet S; Laissue P; Beysen D; Christin-Maitre S; Bouchard P; Veitia R; Fellous M
    Pediatr Endocrinol Rev; 2005 Jun; 2(4):653-60. PubMed ID: 16208278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.
    Fan J; Zhou Y; Huang X; Zhang L; Yao Y; Song X; Chen J; Hu J; Ge S; Song H; Fan X
    Hum Reprod; 2012 Nov; 27(11):3347-57. PubMed ID: 22926839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation.
    Beysen D; Moumné L; Veitia R; Peters H; Leroy BP; De Paepe A; De Baere E
    Hum Mol Genet; 2008 Jul; 17(13):2030-8. PubMed ID: 18372316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXL2: a central transcription factor of the ovary.
    Georges A; Auguste A; Bessière L; Vanet A; Todeschini AL; Veitia RA
    J Mol Endocrinol; 2014 Feb; 52(1):R17-33. PubMed ID: 24049064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional study on a novel missense mutation of the transcription factor FOXL2 causes blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).
    Fan JY; Han B; Qiao J; Liu BL; Ji YR; Ge SF; Song HD; Fan XQ
    Mutagenesis; 2011 Mar; 26(2):283-9. PubMed ID: 21068205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
    Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
    Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutation outside the forkhead domain of FOXL2 causes a severe form of BPES type II.
    Haghighi A; Verdin H; Haghighi-Kakhki H; Piri N; Gohari NS; De Baere E
    Mol Vis; 2012; 18():211-8. PubMed ID: 22312189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency.
    Yang XW; He WB; Gong F; Li W; Li XR; Zhong CG; Lu GX; Lin G; Du J; Tan YQ
    Mol Genet Genomic Med; 2018 Mar; 6(2):261-267. PubMed ID: 29378385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.
    Nuovo S; Passeri M; Di Benedetto E; Calanchini M; Meldolesi I; Di Giacomo MC; Petruzzi D; Piemontese MR; Zelante L; Sangiuolo F; Novelli G; Fabbri A; Brancati F
    J Endocrinol Invest; 2016 Feb; 39(2):227-33. PubMed ID: 26100530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.